← Back to Search

Behavioral Intervention

Online Cognitive Behavioral Therapy for Depression in Heart Disease Patients (COMBAT-DS Trial)

N/A
Recruiting
Led By Debra K Moser, PhD, RN
Research Sponsored by University of Kentucky
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
has had physician-documented acute coronary syndrome (ACS) event
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3, 6 and 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare the effects of two types of online cognitive behavioral therapy for people with heart disease and depressive symptoms living in rural areas.

Who is the study for?
This trial is for rural residents with heart disease who also have moderate to severe depression (PHQ-9 score ≥ 10) and a history of acute coronary syndrome. It's not suitable for those with cognitive impairments, major psychiatric conditions needing extra treatment, or life-threatening non-heart diseases expected to be fatal within a year.
What is being tested?
The study tests two types of online cognitive behavioral therapy: one through video calls and another self-guided on the internet, against usual care. The goal is to see which method better reduces depressive symptoms in rural patients with heart disease.
What are the potential side effects?
Online cognitive behavioral therapy generally does not involve physical side effects like medication might. However, participants may experience emotional discomfort when discussing personal issues during therapy sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have had a heart attack or other heart-related emergency.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3, 6 and 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3, 6 and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in depressive symptoms as a result of intervention effects
Change in intervention effects on depressive symptoms moderated by perceived stigma
Change in intervention effects on depressive symptoms moderated by sex
Secondary study objectives
Change in intervention effects on depressive symptoms moderated by health literacy
Compare all-cause hospitalization rates between intervention groups
Compare medication adherence between groups
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: real-time, face-to-face, video-conferenced CBT (vcCBT)Active Control1 Intervention
vcCBT is cognitive behavioral therapy that consists of eight face-to-face video-conferencing sessions via tablet computers lasting approximately 45 minutes each.
Group II: self-administered internet-based CBT (iCBT)Active Control1 Intervention
iCBT is self-directed cognitive behavioral therapy using an interactive internet program, MoodGYM, which does not include direct interactions with a therapist.

Find a Location

Who is running the clinical trial?

University of KentuckyLead Sponsor
192 Previous Clinical Trials
223,122 Total Patients Enrolled
University of California, Los AngelesOTHER
1,565 Previous Clinical Trials
10,262,689 Total Patients Enrolled
Patient-Centered Outcomes Research InstituteOTHER
574 Previous Clinical Trials
27,078,459 Total Patients Enrolled

Media Library

Online Cognitive Behavioral Therapy (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04986969 — N/A
Heart Disease Research Study Groups: real-time, face-to-face, video-conferenced CBT (vcCBT), self-administered internet-based CBT (iCBT)
Heart Disease Clinical Trial 2023: Online Cognitive Behavioral Therapy Highlights & Side Effects. Trial Name: NCT04986969 — N/A
Online Cognitive Behavioral Therapy (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04986969 — N/A
Heart Disease Patient Testimony for trial: Trial Name: NCT04986969 — N/A
~109 spots leftby Nov 2025